Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trialSeong‐Ho Koh, Kyu‐Yong Lee, Hae Ri Na et al.|Alzheimer s Research & Therapy|2021Cited by 38
Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: <i>Post Hoc</i> Analysis of Severe Impairment Battery SubscalesHyuk Sung Kwon, Sangjae Kim, Seong‐Ho Koh et al.|Dementia and Neurocognitive Disorders|2023Cited by 4